Your browser doesn't support javascript.
loading
Alemtuzumab-induced autoimmune thyroid events in patients with relapsing-remitting multiple sclerosis: A real-life and monocentric experience at a tertiary-level centre.
Manso, Jacopo; Zhu, Yi Hang; Margoni, Monica; Rinaldi, Francesca; Censi, Simona; Carducci, Sofia; Cosma, Chiara; Plebani, Mario; Gallo, Paolo; Mian, Caterina.
Afiliación
  • Manso J; Department of Medicine (DIMED), Endocrinology Unit, Padua University, Padua, Italy.
  • Zhu YH; Department of Medicine (DIMED), Endocrinology Unit, Padua University, Padua, Italy.
  • Margoni M; Veneto Regional Multiple Sclerosis Center (CeSMuV), Padua University Hospital, Padua, Italy.
  • Rinaldi F; Veneto Regional Multiple Sclerosis Center (CeSMuV), Padua University Hospital, Padua, Italy.
  • Censi S; Department of Medicine (DIMED), Endocrinology Unit, Padua University, Padua, Italy.
  • Carducci S; Department of Medicine (DIMED), Endocrinology Unit, Padua University, Padua, Italy.
  • Cosma C; Department of Laboratory Medicine, University Hospital of Padova, Padova, Italy.
  • Plebani M; Department of Laboratory Medicine, University Hospital of Padova, Padova, Italy.
  • Gallo P; Veneto Regional Multiple Sclerosis Center (CeSMuV), Padua University Hospital, Padua, Italy.
  • Mian C; Department of Neurosciences, Padua University, Padua, Italy.
Clin Endocrinol (Oxf) ; 97(3): 331-338, 2022 09.
Article en En | MEDLINE | ID: mdl-34724236
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tiroiditis / Enfermedad de Graves / Esclerosis Múltiple Recurrente-Remitente / Hipotiroidismo / Esclerosis Múltiple Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Endocrinol (Oxf) Año: 2022 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tiroiditis / Enfermedad de Graves / Esclerosis Múltiple Recurrente-Remitente / Hipotiroidismo / Esclerosis Múltiple Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Endocrinol (Oxf) Año: 2022 Tipo del documento: Article País de afiliación: Italia